Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma

Overview of attention for article published in Journal of Asthma and Allergy, December 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 50 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Asma severo eosinofilico, benralizumab efficace e sicuro anche a 2 anni

Pharmastar Italy, 27 Jan 2020

L'impiego a lungo termine di benralizimab si dimostrato efficace e al contempo sicuro in pazienti con asma severo, non…